A survey has shown that UK doctors think AI can help them save time and expand their capacity to care for patients, but three ...

EVERSANA has named Jen Norton as president of its Market Access & Value division, which helps life sciences companies secure ...

AI and connected data are reshaping feasibility and site selection across the clinical development lifecycle, allowing ...

This year, the transformation of China’s biotech and pharma industry into a dominant global player has only accelerated.

Yesterday was National Cancer Survivors’ Day. At ASCO in Chicago last week, three cancer survivors shared parts of their ...

GSK is preparing for its biggest acquisition in more than 10 years, agreeing to buy Nuvalent for $10.6 billion in a move that ...

AstraZeneca is preparing to move its oral GLP-1 agonist elecoglipron into a phase 3 programme in obesity and type 2 diabetes, after reporting encouraging mid-stage results. The results of the phase 2b ...

Incyte has agreed to buy Star Therapeutics subsidiary Vega Therapeutics for $1.25 billion upfront, adding a late-stage drug ...

Alongside the weight-loss result, however, were significant improvements in knee osteoarthritis pain, with an improvement of ...

Boehringer Ingelheim revealed more data behind previously reported top-line results for its dual-acting obesity drug ...

Yet, while excitement around disruptive technologies remains high, bringing genuinely transformative healthcare innovations ...

Roche is preparing to file one BTK-targeting drug for approval, and has just added another with potential across oncology, immunology, and neurology via a deal with Nurix Therapeutics. The licensing ...